血液スクリーニングの世界市場レポート 2025年

血液スクリーニング市場規模は、今後数年で急成長が見込まれます。2029年には53億7,000万米ドルに成長し、CAGRは11.7%となります。予測期間の成長は、ヘルスケアインフラ開発、公衆衛生意識向上プログラム、感染症診断の進歩、世界の健康問題、パンデミック対策に起因しています。予測期間の主な動向としては、感染症の増加、自動化と効率化、輸血需要の増加、輸血安全性の重視、病原体検出の研究などが挙げられます。

感染症の流行の高まりは、今後の血液スクリーニング市場の成長を牽引すると予測されます。血液検査は、感染症に反応して産生される特定の抗体を検出するために日常的に実施されており、ヘルスケア専門家がこれらの疾患を治療し、患者間のさらなるトランスミッションを防止するのに役立っています。例えば、2022年6月、米国の政府機関である国立生物工学情報センター（National Center for Biotechnology Information）は、外来診療における感染症の有病率が過去20年間で約3倍に増加し、1,000人当たり8人から26人に増加したと報告しました。そのため、感染症罹患率の増加が血液スクリーニング市場の拡大に拍車をかけています。

血液スクリーニング市場では、慢性疾患の有病率の増加が成長の大きな促進要因となっています。慢性疾患は、管理は可能だが治癒は不可能な長期疾患であるため、治療中の輸血には正確な血液適合照合が必要となります。輸血の重要性は、自己免疫疾患、血液疾患、がんを含む様々な慢性疾患の管理において明らかです。特に、国立医学図書館による2023年1月からの予測によると、少なくとも1つの慢性疾患を持つ50歳以上の高齢者の数は大幅に増加し、2050年には1億4,266万人に達すると予想されています。慢性疾患の有病率の上昇と互換性のある血液スクリーニングの需要は、血液スクリーニング市場の拡大に大きく貢献しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界血液スクリーニング PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、制約）
• 最終用途産業の分析
• 世界の血液スクリーニング市場：成長率分析
• 世界の血液スクリーニング市場の実績：規模と成長, 2019-2024
• 世界の血液スクリーニング市場の予測：規模と成長, 2024-2029, 2034F
• 世界血液スクリーニング総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の血液スクリーニング市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 試薬とキット
• 機器
• ソフトウェアとサービス
• 世界の血液スクリーニング市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 核酸検査
• 酵素免疫測定法（ELISA）
• 迅速検査
• ウエスタンブロットアッセイ
• 次世代シーケンシング（NGS）
• 世界の血液スクリーニング市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血液銀行
• 診断センターおよび病理学研究室
• 病院
• クリニック
• 外来手術センター（ASC）
• 世界の血液スクリーニング市場、試薬とキットの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断試薬
• 検査キット
• 世界の血液スクリーニング市場、楽器のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自動分析装置
• 手動テスト装置
• 世界の血液スクリーニング市場ソフトウェアとサービスのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 検査情報管理システム（LIMS）
• データ分析ソフトウェア
• サポートおよびコンサルティングサービス

第7章 地域別・国別分析

• 世界の血液スクリーニング市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の血液スクリーニング市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 血液スクリーニング市場：競合情勢
• 血液スクリーニング市場：企業プロファイル
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • bioMerieux S.A. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bio-Rad Laboratories Inc.
• Thermo Fisher Scientific Inc.
• Ortho Clinical Diagnostics Inc.
• Beckman Coulter Inc.
• Siemens Healthineers AG
• GE Healthcare
• DiaSorin S.p.A.
• Merck KGaA
• PerkinElmer Inc.
• Bio-Techne Corporation
• Roche Diagnostics GmbH
• Danaher Corporation
• Sysmex Corporation
• Natera Inc.
• GenMark Diagnostics Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 血液スクリーニング市場2029：新たな機会を提供する国
• 血液スクリーニング市場2029：新たな機会を提供するセグメント
• 血液スクリーニング市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Blood screening involves the examination of blood, plasma, or blood components intended for transfusion or incorporation into blood-based products. This process aims to detect antibodies, tumor markers, disease-causing agents, or indicators of illnesses, and to assess the effectiveness of treatments.

The primary products used in blood screening include reagents and kits, instruments, software, and associated services. Reagents are compounds or substances enabling reactions crucial for detecting, measuring, or preparing components due to their biological or chemical activity. Kits, on the other hand, are test kits used in laboratory settings or in the field to identify specific compounds in a sample. Technologies utilized in blood screening encompass nucleic acid testing, enzyme-linked immunosorbent assay (ELISA), rapid tests, western blot assays, and next-generation sequencing (NGS). These screening methods find application in various healthcare settings such as blood banks, diagnostic centers, pathology labs, hospitals, clinics, and ambulatory surgical centers (ASCs).

The blood screening market research report is one of a series of new reports from The Business Research Company that provides blood screening market statistics, including blood screening industry global market size, regional shares, competitors with a blood screening market share, detailed blood screening market segments, market trends and opportunities, and any further data you may need to thrive in the blood screening industry. This blood screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blood screening market size has grown strongly in recent years. It will grow from $3.15 billion in 2024 to $3.45 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to increased blood transfusion requirements, rising prevalence of transmissible diseases, government regulations and standards, increasing blood donations and collection, global health concerns and pandemics.

The blood screening market size is expected to see rapid growth in the next few years. It will grow to $5.37 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to healthcare infrastructure development, public health awareness programs, advancements in infectious disease diagnostics, global health concerns and pandemic preparedness. Major trends in the forecast period include rise in infectious diseases, automation and efficiency, rising blood transfusion demands, focus on transfusion safety, research in pathogen detection.

The rising prevalence of infectious diseases is anticipated to drive the growth of the blood screening market in the future. Blood tests are routinely conducted to detect specific antibodies produced in response to infectious agents, assisting healthcare professionals in treating these diseases and preventing further transmission among patients. For example, in June 2022, the National Center for Biotechnology Information, a U.S.-based government agency, reported that the prevalence of infectious diseases in outpatient care has nearly tripled over the past two decades, increasing from 8 to 26 per 1,000. Therefore, the growing incidence of infectious diseases is fueling the expansion of the blood screening market.

In the blood screening market, the increasing prevalence of chronic diseases is a significant driver of growth. Chronic diseases, manageable but not curable long-term conditions, necessitate precise blood compatibility matching for transfusions during medical treatments. The importance of blood transfusions is evident in managing various chronic conditions, including autoimmune diseases, hematological disorders, and cancers. Notably, projections from January 2023 by the National Library of Medicine indicate a substantial increase in the number of individuals aged 50 and older with at least one chronic condition, expected to reach 142.66 million by 2050. The rising prevalence of chronic diseases and the demand for compatible blood screening contribute significantly to the expanding blood screening market.

Leading companies in the blood screening market are advancing technologies such as liquid biopsy to improve early cancer detection, enhance treatment monitoring, and support personalized medicine strategies. A liquid biopsy is a minimally invasive procedure that examines blood or other bodily fluids to identify cancer cells or genetic material from tumors. For example, in November 2023, Guardant Health, Inc., a biotechnology firm based in the U.S., introduced its Shield blood-based screening tests. This test analyzes cell-free DNA (cfDNA) in the bloodstream, helping to identify the presence of colorectal tumors or precancerous lesions by detecting specific alterations in DNA fragments released into the blood by cancer cells.

Leading companies in the blood screening market are innovating technologies such as Vacutainers to improve the efficiency, accuracy, and safety of blood collection and testing procedures. A Vacutainer is a vacuum-sealed tube designed for collecting and preserving blood samples for laboratory analysis. For example, in April 2024, Becton Dickinson, a U.S.-based medical device manufacturer, introduced the UltraTouch feature. This advancement enables the use of a thinner needle, which is essential for reducing pain during insertion. The thinner needle aims to enhance patient comfort during blood collection procedures.

In October 2022, Pfizer Inc., a U.S.-based pharmaceutical and biotechnology company, acquired Global Blood Therapeutics, Inc. for an undisclosed sum. This acquisition is intended to enhance Pfizer's portfolio, expand its research and development capabilities, and strengthen its position in the market. Global Blood Therapeutics, Inc. is a U.S.-based biotechnology firm that focuses on providing innovative therapies for sickle cell disease and other rare blood disorders.

Major companies operating in the blood screening market include Abbott Laboratories, Grifols S.A., Becton Dickinson and Company, F. Hoffmann-La Roche AG, bioMerieux S.A., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Ortho Clinical Diagnostics Inc., Beckman Coulter Inc., Siemens Healthineers AG, GE Healthcare, DiaSorin S.p.A., Merck KGaA, PerkinElmer Inc., Bio-Techne Corporation, Roche Diagnostics GmbH, Danaher Corporation, Sysmex Corporation, Natera Inc., GenMark Diagnostics Inc., QIAGEN N.V., Hologic Inc., Luminex Corporation, Trinity Biotech plc, Fujirebio Inc., OraSure Technologies Inc., Immunetics Inc., Accelerate Diagnostics Inc., Cepheid Inc., T2 Biosystems Inc., Haemonetics Corporation, HTG Molecular Diagnostics Inc., Verax Biomedical Inc.

North America was the largest region in the blood screening market in 2024. The regions covered in the blood screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the blood screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The blood screening market consists of revenues earned by entities by providing transcription mediated amplification (TMA) and real-time PCR. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood screening market also includes sales of analyzer, photo colorimeter, flame photometer, hemoglobin meter, blood roller mixer, dry bath incubators, and differential blood counter. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blood Screening Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on blood screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for blood screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The blood screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Reagents And Kits; Instruments; Software And Services
• 2) By Technology: Nucleic Acid Testing; Enzyme-Linked Immunosorbent Assay (ELISA); Rapid Tests; Western Blot Assays; Next-Generation Sequencing (NGS)
• 3) By End User: Blood Banks; Diagnostic Centers And Pathology Labs; Hospitals; Clinics; Ambulatory Surgical Centers (ASCs)
• Subsegments:
• 1) By Reagents And Kits: Diagnostic Reagents; Testing Kits
• 2) By Instruments: Automated Analyzers; Manual Testing Equipment
• 3) By Software And Services: Laboratory Information Management Systems (LIMS); Data Analysis Software; Support And Consulting Services
• Companies Mentioned: Abbott Laboratories; Grifols S.A.; Becton Dickinson and Company; F. Hoffmann-La Roche AG; bioMerieux S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Blood Screening Market Characteristics

3. Blood Screening Market Trends And Strategies

4. Blood Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Blood Screening Growth Analysis And Strategic Analysis Framework

• 5.1. Global Blood Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Blood Screening Market Growth Rate Analysis
• 5.4. Global Blood Screening Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Blood Screening Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Blood Screening Total Addressable Market (TAM)

6. Blood Screening Market Segmentation

• 6.1. Global Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents and Kits
• Instruments
• Software and Services
• 6.2. Global Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nucleic Acid Testing
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Rapid Tests
• Western Blot Assays
• Next-Generation Sequencing (NGS)
• 6.3. Global Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Banks
• Diagnostic Centers and Pathology Labs
• Hospitals
• Clinics
• Ambulatory Surgical Centers (ASCs)
• 6.4. Global Blood Screening Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Reagents
• Testing Kits
• 6.5. Global Blood Screening Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Automated Analyzers
• Manual Testing Equipment
• 6.6. Global Blood Screening Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laboratory Information Management Systems (LIMS)
• Data Analysis Software
• Support And Consulting Services

7. Blood Screening Market Regional And Country Analysis

• 7.1. Global Blood Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Blood Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Blood Screening Market

• 8.1. Asia-Pacific Blood Screening Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Blood Screening Market

• 9.1. China Blood Screening Market Overview
• 9.2. China Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Blood Screening Market

• 10.1. India Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Blood Screening Market

• 11.1. Japan Blood Screening Market Overview
• 11.2. Japan Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Blood Screening Market

• 12.1. Australia Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Blood Screening Market

• 13.1. Indonesia Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Blood Screening Market

• 14.1. South Korea Blood Screening Market Overview
• 14.2. South Korea Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Blood Screening Market

• 15.1. Western Europe Blood Screening Market Overview
• 15.2. Western Europe Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Blood Screening Market

• 16.1. UK Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Blood Screening Market

• 17.1. Germany Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Blood Screening Market

• 18.1. France Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Blood Screening Market

• 19.1. Italy Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Blood Screening Market

• 20.1. Spain Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Blood Screening Market

• 21.1. Eastern Europe Blood Screening Market Overview
• 21.2. Eastern Europe Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Blood Screening Market

• 22.1. Russia Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Blood Screening Market

• 23.1. North America Blood Screening Market Overview
• 23.2. North America Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Blood Screening Market

• 24.1. USA Blood Screening Market Overview
• 24.2. USA Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Blood Screening Market

• 25.1. Canada Blood Screening Market Overview
• 25.2. Canada Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Blood Screening Market

• 26.1. South America Blood Screening Market Overview
• 26.2. South America Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Blood Screening Market

• 27.1. Brazil Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Blood Screening Market

• 28.1. Middle East Blood Screening Market Overview
• 28.2. Middle East Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Blood Screening Market

• 29.1. Africa Blood Screening Market Overview
• 29.2. Africa Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Blood Screening Market Competitive Landscape And Company Profiles

• 30.1. Blood Screening Market Competitive Landscape
• 30.2. Blood Screening Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. bioMerieux S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Blood Screening Market Other Major And Innovative Companies

• 31.1. Bio-Rad Laboratories Inc.
• 31.2. Thermo Fisher Scientific Inc.
• 31.3. Ortho Clinical Diagnostics Inc.
• 31.4. Beckman Coulter Inc.
• 31.5. Siemens Healthineers AG
• 31.6. GE Healthcare
• 31.7. DiaSorin S.p.A.
• 31.8. Merck KGaA
• 31.9. PerkinElmer Inc.
• 31.10. Bio-Techne Corporation
• 31.11. Roche Diagnostics GmbH
• 31.12. Danaher Corporation
• 31.13. Sysmex Corporation
• 31.14. Natera Inc.
• 31.15. GenMark Diagnostics Inc.

32. Global Blood Screening Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Blood Screening Market

34. Recent Developments In The Blood Screening Market

35. Blood Screening Market High Potential Countries, Segments and Strategies

• 35.1 Blood Screening Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Blood Screening Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Blood Screening Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer